Thus, considering the lack of conclusive data regarding the ω3 fatty acid in mediating the resolution of inflammation and its consequences through GPR120 in immune cells of overweight/obese and NAFLD individuals, the present study is crucial for the characterization of the signaling mechanisms and molecules that mediate these effects. The gene discussed is FFAR4; the disease is metabolic dysfunction-associated steatotic liver disease.